Genomma Lab stock at EUR 0.69 pre-market ahead of Xetra open
Published on 10/21/2026 at 08:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSHealth products and schedule
- Genomma Lab creates, promotes and distributes over-the-counter medicines and personal-care products.
- The company’s investor relations page lists a 3Q-2026 Earnings Call Advisory dated October 1, 2026.
- Genomma Lab stock trades pre-market at EUR 0.69 at 8:46 a.m. CEST at Lang & Schwarz on October 21, 2026.
Genomma Lab creates, promotes and distributes over-the-counter pharmaceuticals and personal-care products across Mexico and international markets. The stock trades pre-market at EUR 0.69 at 8:46 a.m. CEST at Lang & Schwarz on October 21, 2026.
Pre-market indications
The bid is EUR 0.67 and the ask is EUR 0.71, a spread of 5.80 percent. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Genomma Lab stock.
The group and its schedule
Genomma Lab earns revenue by creating, promoting and distributing over-the-counter medicines and personal-care items in its markets, according to its company profile and investor-relations materials. The company’s investor relations page lists a 3Q-2026 Earnings Call Advisory dated October 1, 2026, and identifies Investor Day 2026 as a company event. Genomma Lab’s investor relations page provides the company’s latest listed releases and event information. Market context: Latest market reports.
